EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Prognostic significance of some clinical morphological and cytogenetic findings in refractory anemia and refractory anemia with sideroblasts



Prognostic significance of some clinical morphological and cytogenetic findings in refractory anemia and refractory anemia with sideroblasts



Blut 52(1): 35-44



In 27 patients initially diagnosed as refractory anaemia (RA) or RA with sideroblasts (RA-S) according to the FAB-classification a number of clinical, morphological and cytogenetic parameters were correlated for prognostic significance. From these correlations it emerged that severe cytopenia is centrally positioned with regard to clinical course in RA and RA-S. Positive correlations were found to initial diagnosis, clonal cytogenetic abnormalities, progression to RA with an excess of blasts (RAEB) or acute myeloid leukaemia (AML), the percentage of bone marrow blast cells and prolonged half-life for radioactively labeled iron. The degree of peripheral blood granulocytopenia, alone, was correlated to bone marrow hypoplasia. Moreover, the frequency of abnormal karyotypes was inversely correlated to bone marrow cellularity and proportional to the frequency of bone marrow blast cells. From these relationships it may be proposed that chromosome abnormalities are associated with prolonged blast cell generation times and inhibition of blast cell maturation resulting in reduced marrow cellularity and blast cell accumulation, and, in the peripheral blood, falling percentages of neutrophil granulocytes. With the blast cell accumulation the bone marrow cellularity again becomes hyperplastic and the preleukaemic condition is transformed into RAEB or AML.

(PDF emailed within 1 workday: $29.90)

Accession: 006196389

Download citation: RISBibTeXText



Related references

The prognostic significance of cytological histological and cytogenetic findings in refractory anemia ra and ra with sideroblasts a follow up study. Blut 54(4): 231-238, 1987

Prognostic significance of some clinical, morphological and cytogenetic findings in refractory anaemia (RA) and RA with sideroblasts. Blut 52(1): 35-43, 1986

Myelodysplastic syndromes: prognostic significance of multilineage dysplasia in patients with refractory anemia or refractory anemia with ringed sideroblasts. Blood 99(10): 3870-1; Author Reply 3871, 2002

Factors influencing nonleukemic death in refractory anemia, refractory anemia with ring sideroblasts, and refractory anemia with excess of blasts. Cancer Research 47(13): 3599-3602, 1987

Prognostic value of multilineage dysplasia and bone marrow histology in the FAB subgroups of refractory anemia and refractory anemia with ringed sideroblasts and possible relevance in the new WHO proposal. Leukemia Research 27(Supplement 1): S19-S20, 2003

Refractory anemia with severe dysplasia: clinical significance of morphological features in refractory anemia. Leukemia 12(4): 482-485, 1998

Refractory anemia with severe dysplasia: Clinical significance of morphological features in refractory anemia. Leukemia (Basingstoke) 12(4): 482-485, April, 1998

Development of refractory anemia with ring sideroblasts associated with thrombocytosis from pre-existing refractory anemia with ring sideroblasts through acquisition of Jak2 V617F mutation. Leukemia & Lymphoma 52(12): 2405-2407, 2012

The prognostic significance of cytological, histological and cytogenetic findings in refractory anaemia (RA) and RA with sideroblasts. Annals of Hematology 54(4): 231-238, 1987

Improved identification of refractory anemia and refractory anemia with ringed sideroblasts using red cell volume distribution width. American Journal of Clinical Pathology 101(3): 391, 1994

Plasma proteome changes associated with refractory anemia and refractory anemia with ringed sideroblasts in patients with myelodysplastic syndrome. Proteome Science 11(1): 14-14, 2013

Independent prognostic significance of day 21 cytogenetic findings in newly-diagnosed acute myeloid leukemia or refractory anemia with excess blasts. Haematologica 88(7): 733-736, 2003

Immature and mature monocyte-derived dendritic cells in myelodysplastic syndromes of subtypes refractory anemia or refractory anemia with ringed sideroblasts display an altered cytokine profile. Leukemia Research 31(10): 1373-1382, 2006

Translocation (1;22) in refractory anemia and the prognostic significance of karyotypic abnormalities in refractory anemia. Cancer Genetics and Cytogenetics 106(1): 72-75, 1998

Cytogenetic findings in 121 patients with refractory anemia Prognostic value. Cytogenetics & Cell Genetics 77(1-2): 138, 1997